Finance

People have long been willing to pay for healthcare despite rising costs, with Medtronic and Eli Lilly offering two different angles on the space.

Nvidia just hit another record. It’s closing in on $6 trillion.

Novo Nordisk has a huge opportunity in GLP-1 weight-loss drugs, but it has to prove it can use that success to build for the future.

Consumers are making up for lost travel time.

Competition is increasing for DraftKings.

The company announced a splashy new AI cloud contract with an unnamed client.

Demand for energy is soaring, and that’s great news for Bloom Energy.

Applied Materials held steady for most of two years before accelerating, while Nvidia’s revenue nearly tripled over the same span.

Its upcoming industry conference is going to be a barn-burner.

Picking winners and losers in the artificial intelligence industry hasn’t been easy.

Two analysts raised their price targets on the electronic components maker.

An analyst feels it’s currently the No. 1 stock in its field.

A federal jury rejected all of Joby’s counterarguments.

It’s about to join a famous small-cap stock index.

JPMorgan’s Overweight call and $19 price target, combined with Corteva’s move into the S&P MidCap 400, fueled a 12% surge, today, Oct. 6, 2026.

Today, Oct. 6, 2026, the chipmaker lifted near- and long-term targets at Investor Day, signaling stronger AI infrastructure demand ahead.

The AI leader’s eagerly awaited public offering is delayed as investors weigh the big implications of owning the stock.

The company struggled with labor unrest in Vietnam.

A basket of these five semiconductor stocks should produce strong returns in the coming years.

One commands mobile connectivity and licensing; the other dominates AI memory chips with a 44% net margin. Their risk profiles and valuations diverge sharply.